EBS earnings: a negative outcome, -6.4%

On February 25, 2022, Emergent BioSolutions Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.4% in the window around the event. It had already run -6.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.